在患有多发性硬化症的人中管理可修改性并发症的重要性:叙述性审查
Viviana Nociti1,2, Marina Romozzi1
1Centro Sclerosi Multipla, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Journal of personalized medicine
|November 25, 2023
概括
多发性硬化症 (MS) 是一种慢性中枢神经系统疾病. 本综述强调了可预防的并发症和风险因素,如血管问题和生活方式选择,影响MS患者的疾病管理.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 多发性硬化症 (MS) 是中枢神经系统 (CNS) 的慢性,炎症性,脱髓化疾病.
- 增加MS患者的预期寿命 (PwMS) 需要关注并发症.
- 血管并发症和生活方式因素在PwMS中普遍存在并可修改.
研究的目的:
- 审查目前关于PwMS可预防和可修改的并发症和风险因素的证据.
- 讨论这些因素对MS疾病进展和管理的影响.
- 为了解决血管和MS病变的重叠特征所带来的诊断挑战.
主要方法:
- 对当前证据的文献综述.
- 对MS的并发症和风险因素研究的分析.
- 综合有关临床和放射学特征的信息.
主要成果:
- 血管并发症在PwMS中是常见的和可修改的.
- 吸烟和饮酒等生活方式因素也与此相关.
- 将血管病变与多发性硬化病变区分开来,带来了诊断挑战.
结论:
- 管理可修改的并发症和风险因素对PwMS至关重要.
- 解决血管健康和生活方式的选择可以影响MS管理.
- 需要进一步的研究来区分血管和MS相关的病理.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Methods of Documentation VI: Case Management Model
574
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
574
COPD: Management Using Bronchodilators and Corticosteroids
214
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
214
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K
Cystic Fibrosis: Management
172
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
172
Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289


